MP40: Prostate Cancer: Detection & Screening I

Poster Session Moderator(s)

• 

  Adam Kibel, MD (he/him/his)

  Elliott Carr Cutler Professor of Surgery, Chair, Department of Urology
  Mass General Brigham, Harvard University
• 

  Zeyad Schwen, MD
• 

  Karim Touijer, MD

  Memorial Sloan Kettering Cancer Center

Presentations:

• 1:00 PM – 3:00 PM CST

  MP40-01: Differentially Expressed Glycoproteins in Pre- and Post- Digital Rectal Examination Urine Samples for Detecting Aggressive Prostate Cancer
  

  Poster Presenter: Gregory T. Chesnut, MD
• 1:00 PM – 3:00 PM CST

  MP40-02: Baseline PSA levels in midlife & future development of lethal prostate cancer: A diverse North American cohort analysis
  

  Poster Presenter: Matthew James Davis, MBA
• 1:00 PM – 3:00 PM CST

  MP40-04: Long-term tumor necrosis factor-alpha inhibitor use decreases the risk of Prostate Cancer
  

  Poster Presenter: Conor Driscoll, MD (he/him/his) – Northwestern Urology
• 1:00 PM – 3:00 PM CST

  MP40-05: Elevated IsoPSA is associated with both Cribriform and Intraductal Carcinoma Morphologic Features at the Time of Prostate Biopsy
  

  Poster Presenter: Zaeem Lone, BA – Roswell Park Comprehensive Cancer Center
• 1:00 PM – 3:00 PM CST

  MP40-06: Early Detection of prostate cancer: an optimized urine smart test
  

  Poster Presenter: Daniele Amparore, PhD – University of Turin, Italy
• 1:00 PM – 3:00 PM CST

  MP40-07: Has the introduction of multiparametric magnetic resonance imaging of the prostate and targeted biopsies led to a risk of overgrading of high risk prostate cancer? Results from a contemporary large multi-institutional series.
  

  Poster Presenter: Gabriele Sorce, MD – San Raffaele
• 1:00 PM – 3:00 PM CST

  MP40-08: Can we avoid systematic biopsies and do only targeted biopsies when there is a discernible lesion in MRI scan prostate with PIRADS scores 4 or 5? A single high volume centre retrospective data analysis
  

  Poster Presenter: Anish Kooplikattil Pushkaran, MD,FRCS
• 1:00 PM – 3:00 PM CST

  MP40-09: External validation of a Multiparametric Magnetic Resonance Imaging volumetric model to predict the utility of systematic biopsies at the time of targeted biopsy
  

  Poster Presenter: Antonella Ninivaggi, MD (she/her/hers) – University Of Foggia-Department of Urology
• 1:00 PM – 3:00 PM CST

  MP40-10: Creating High Quality Synthetic Genitourinary Tissue Images From Histology Repositories to Overcome Limitations with the use of Clinical Trial data in AI models
  

  Poster Presenter: Derek Van Booven, BS – University of Miami
• 1:00 PM – 3:00 PM CST

  MP40-11: Contribution of Gleason pattern 4 prostate cancer tissue to pre-operative PSA values in intermediate risk Prostate Cancer: Results from 4 860 RP specimens
  

  Poster Presenter: Fabian Falkenbach, MD (he/him/his)
• 1:00 PM – 3:00 PM CST

  MP40-12: Intensified prostate cancer screening in germline carriers of rare pathogenic variants: interim results from the initial screening round of the PROGRESS study
  

  Poster Presenter: Keyan Salari
• 1:00 PM – 3:00 PM CST

  MP40-13: ¹⁸F-rhPSMA-7.3 Detection Rates in Patients with Recurrence of Prostate Cancer Following Primary Treatment with Radiation Therapy: Results from the SPOTLIGHT Study
  

  Poster Presenter: Brian T. Helfand, MD – Endeavor Health- Northshore University Healthsyste
• 1:00 PM – 3:00 PM CST

  MP40-14: Are EAU Risk Groups Reliable in the Stratification of Men with Biochemical Recurrence after Radical Prostatectomy and Restaged with PSMA-PET?
  

  Poster Presenter: Giorgio Gandaglia, MD (he/him/his) – UniSR
• 1:00 PM – 3:00 PM CST

  MP40-15: The diagnostic value of PSMA PET/CT in men with newly diagnosed International Society of Urological Pathology grade group 3 intermediate-risk prostate cancer
  

  Poster Presenter: Marinus Jan Hagens, MD (he/him/his)
• 1:00 PM – 3:00 PM CST

  MP40-16: Microultrasound in the Detection of the Index Lesion in Prostate Cancer
  

  Poster Presenter: Adriana Marcela Pedraza Bermeo, MD – Cleveland Clinic
• 1:00 PM – 3:00 PM CST

  MP40-17: Clinical and high-resolution micro-ultrasound risk factors for detecting clinically significant prostate cancer in men with PI-RADS 3 lesions: update from a large single center experience.
  

  Poster Presenter: Pier Paolo Pp Avolio, MD – Humanitas University
• 1:00 PM – 3:00 PM CST

  MP40-18: Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive Versus Software Fusion, A Multicenter Analysis
  

  Poster Presenter: Michael Hung, MD (he/him/his)
• 1:00 PM – 3:00 PM CST

  MP40-19: West-African Ancestry Can Aid Prediction of High-Grade Prostate Cancer in Black-Tailored Risk Calculator
  

  Poster Presenter: Neil A. Mistry
• 1:00 PM – 3:00 PM CST

  MP40-20: Can We Predict for Missed Clinically Significant Prostate Cancers on MRI-Targeted Biopsy alone?
  

  Poster Presenter: Woon Chau Tsang